Clinical Trial: Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss: a Pilot Trial.

U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07280403) titled 'Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss: a Pilot Trial.' on Dec. 01.

Brief Summary: The goal of this clinical trial is to determine the effect of a low carbohydrate higher protein diet, modelled after the Atkins program on weight loss, glycemic control, risk markers of cardiovascular disease and body composition in patients taking semaglutide.

Participants will:

* Be randomized to follow either a low carb, higher protein diet or a low fat diet for 3 months.

* Visit the clinic at week 2, 4, 8 and 12 to meet with a dietician, fill out a symptoms quest...